UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER...
0001822929 false 00-0000000 0001822929 2023-04-07 2023-04-07 0001822929...
Eucrates Biomedical Acquisition Corp. Announces Liquidation PR Newswire NEW YORK, April 11, 2023 NEW YORK...
0001822929 false 00-0000000 0001822929 2023-03-30 2023-03-30 0001822929...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM...
0001822929 false 00-0000000 0001822929 2023-02-15 2023-02-15 0001822929...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE...
1047962610479626104796261047962629794992979499297949929794990001822929--12-312022Q3falsefalse29794992979499http://fasb.org/us-gaap/2022#FairValueAd...
0001822929 false 00-0000000 0001822929 2022-11-07 2022-11-07 0001822929...
0001822929 false --12-31 00-0000000 0001822929 2022-10-25 2022-10-25...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFIC...
104796265216767104796265216767297949927151680.280.280.620.620001822929--12-312021FY0029794992979499000029794992979499UnlimitedUnlimitedUnlimitedUnl...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange...
vgg3141w1142_020822.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.